Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...
Please provide your email address to receive an email when new articles are posted on . Fears associated with needles may cause patients and caregivers to delay their use of epinephrine autoinjectors.
The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen. The ...
Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...
The FDA has approved a nasal spray, neffy, as the first non-needle means of delivering rescue epinephrine during anaphylaxis The spray is meant for adults and kids weighing over 66 pounds FRIDAY, Aug.